We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Corticosteroid Treatment Improves Adult Sepsis Outcomes

By HospiMedica International staff writers
Posted on 23 Jan 2019
Print article
A new study concludes that administration of corticosteroids to patients with sepsis is associated with significant improvement in health care outcomes and reduced mortality.

Researchers at Sichuan University (Chengdu, China), Southwest Hospital of Army Medical University (Chongqing, China), and other institutions conducted a systematic review and meta-analysis of studies to examine the efficacy and safety of corticosteroids in patients with sepsis. In all, 37 randomized clinical trials (RCTs) that met inclusion criteria were used to compare administration of corticosteroids with placebo or standard supportive care in 9,564 adult patients with sepsis.

The results revealed that corticosteroid use was associated with reduced 28-day mortality, intensive care unit (ICU) mortality, and in-hospital mortality. Corticosteroids were also significantly associated with increased shock reversal at day seven, vasopressor-free days, ICU length of stay, sequential organ failure assessment score at day seven, and time to resolution of shock. But corticosteroid use was also associated with increased risk of hyperglycemia and hypernatremia. The study was published on December 21, 2018, in JAMA Internal Medicine.

“Corticosteroids have been used as adjuvant therapy for sepsis for more than 50 years without hard evidence to guide patient selection. Physicians have used their clinical judgment to decide how to use corticosteroids,” concluded lead author Chao You, MD, of Sichuan University, and colleagues. “These findings appear to indicate that corticosteroids should be prescribed at a low dose and for a long course. Future studies are needed to associate personalized medicine with clinical phenotyping, genotyping, or metabolomics with the treatment of sepsis.”

Sepsis is characterized by a whole-body inflammatory state caused by the immune system's response to a serious infection, most commonly bacteria, but also fungi, viruses, and parasites in the blood, urinary tract, lungs, skin, or other tissues. Symptoms of sepsis include those related to a specific infection, and are usually accompanied by high fevers, hot, flushed skin, elevated heart rate, hyperventilation, altered mental status, swelling, and low blood pressure. Sepsis causes millions of deaths globally each year.

Related Links:
Sichuan University
Southwest Hospital of Army Medical University

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
4K SURGICAL MONITOR
TM343
New
Antimicrobial Barrier Dressing
ACTICOAT FLEX

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.